|
Lenard A. Adler, MD, has been the Director of the Adult ADHD Program in the Departments of Psychiatry at New York University (NYU) School of Medicine in New York, New York since 1995. He is also Associate Professor of Psychiatry and Child and Adolescent at the NYU School of Medicine. He obtained a BA in Economics from the College of Arts and Sciences at Cornell University in 1978. He earned his MD from Emory University School of Medicine in 1982, and went on to serve an internship in Medicine, Neurology, and Psychiatry, followed by a residency in Psychiatry, acting as Chief Resident from 1983 to 1986, at NYU School of Medicine. He has been interviewed numerous times in national media venues, including 60 Minutes and the Today Show, as well as The New York Times, USA Today and U.S. News & World Report, discussing his treatment methods for adults with ADHD.
Dr. Adler has been a principle contributor to numerous new treatment trials in ADHD and in the development of new scales to diagnose and evaluate symptoms of adult ADHD.
A Diplomat in Psychiatry to the American Board of Psychiatry and Neurology, Dr. Adler is board-certified by the National Board of Medical Examiners. He is an active investigator and frequent lecturer, who has authored and coauthored more than 60 peer-reviewed articles and book chapters. He is also author of the popular book on Adult ADHD: SCATTERED MINDS, G.P. Putnam’s Sons 2006.
|
|
Potential Conflict of Interest Disclosure in the last Year
• Dr. Adler has no stock ownership to disclose
• Dr. Adler has received grant/research support from Abbott Laboratories, Bristol-Myers Squibb, Merck & Co., Pfizer, Shire, Eli Lilly, Ortho-McNeil/Janssen/Johnson and Johnson, and the National Institute on Drug Abuse
• He is on the speakers’ bureau for Ortho McNeil/Jannsen/Johnson and Johnson, and Shire
• Dr. Adler is also a consultant or on the advisory board for Abbott Laboratories, Eli Lilly, Major League Baseball, Merck, Mindsite, Organon, Ortho McNeil/Jannsen/Johnson and Johnson, Pfizer, Psychogenics, Sanofi-Aventis Pharmaceuticals, and Shire
• In the prior year, Dr. Adler has received grant/research support, or consulted with, or served on advisory boards, or speaker’s bureau from: Abbott Laboratories, Bristol-Myers Squibb, Cephalon, Cortex Pharmaceuticals, Eli Lilly, Major League Baseball, Merck & Co., Mindsite, National Institute on Drug Abuse, New River Pharmaceuticals, Novartis Pharmaceuticals, Organon, Ortho McNeill/Jannsen/Johnson and Johnson, Pfizer, Psychogenics, Sanofi-Aventis Pharmaceuticals, and Shire
• He has received royalty payments (as inventor) from New York University for license of adult ADHD scales and training materials since 2004
|